Provision of on-site medical care to patients with hepatitis C in drug treatment units

Journal of Health Care for the Poor and Underserved

Volumn 15, Issue 4, 2004, Pages 663-671

  Vassilev, Zdravko P ^a,b   Strauss, Shiela M ^e   Astone, Janetta M ^a   Friedmann, Peter D ^c   Des Jarlais, Don C ^d  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e NONE

Author keywords

Drug abuse treatment; Drug users; Hepatitis C; Medical care

Indexed keywords

ARTICLE; HEALTH CARE ORGANIZATION; HEALTH CENTER; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS C; HOSPITAL; HUMAN; MEDICAL CARE; MEDICAL EXAMINATION; MEDICAL STAFF; PATIENT CARE; UNITED STATES;

EID: 8844256268     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.2004.0075     Document Type: Article

References (32)

1. McCarthy JJ, Flynn N. Hepatitis C in methadone maintenance patients: prevalence and public policy implications. J Addict Dis 2001;20(1):19-31.
2. Lorvick J, Kral AH, Seal K, et al. Prevalence and duration of hepatitis C among injection drug users in San Francisco, California. J Public Health 2001 Jan;91(1):46-7.
3. Tennant F. Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts. J Addict Dis 2001;20(1):9-17.
4. Dhopesh VP, Taylor KR, Burke WM. Survey of hepatitis B and C in addiction treatment unit. Am J Drug Alcohol Abuse 2000 Nov;26(4):703-7.
5. Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002 Mar;92(3):385-7.
6. Metsch LR, Pereyra M, Brewer TH. Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users. J Subst Abuse 2001;13(1-2):155-67.
7. Chitwood DD, Sanchez J, Comerford M, et al. Primary preventive health care among injection drug users, other sustained drug users, and non-users. Subst Use Misuse 2001 May-Jun;36(6-7):807-24.
8. Downing M, Mulia N, Vernon K, et al. Voices from the field: providers discuss HIV counseling and testing programs for drug users. AIDS Public Policy J 2000 Summer;15(2):48-64.
9. Demas P, Schoenbaum EE, Wills TA, et al. Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev 1995 Oct;7(5):429-42.
10. Johnston D, Stall R, Smith K. Reliance by gay men and intravenous drug users on friends and family for AIDS-related care. AIDS Care 1995;7(3):307-19.
11. Chitwood DD, McBride DC, French MT, et al. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse 1999 Mar-Apr;34(4-5):727-46.
12. Edlin BR, Seal KH, Lorvick J, et al. Is it justifiable to withhold treatment for hepatitis C from illicit drug users? N Engl J Med 2001 Jul 19;345(3):211-5.
13. Davis GL, Rodrigue JR. Treatment of chronic hepatitis C in active drug users. N Engl J Med 2001 Jul 19;345(3):215-17.
14. Stephenson J. Former addicts face barriers to treatment for HCV. JAMA 2001 Feb 28;285(8):1003-5.
15. Johnson ME, Fisher DG, Fenaughty A, et al. Hepatitis C virus and depression in drug users. Am J Gastroenterol 1998 May;93(5):785-9.
16. Schafer M, Boetsch T, Laakmann G. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C. Addiction 2000 Jul;95(7):1101-4.
17. Contoreggi C, Rexroad VE, Lange WR. Current management of infectious complications in the injecting drug user. J Subst Abuse Treat 1998 Mar-Apr;15(2):95-106.
18. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997 Sep;26(3 Suppl 1):2S-10S.
19. EASL international consensus conference on hepatitis C: Consensus statement. J Hepatol 1999 May;30(5):956-61.
20. Sherman M. Management of viral hepatitis: clinical and public health perspectives - a consensus statement. Can J Gastroenterol 1997 Jul-Aug;11(5):407-16.
21. Strauss SM, Falkin GP, Vassilev Z, et al. A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat 2002 Mar;22(2):55-62.
22. Umbricht-Schneiter A, Ginn DH, Pabst KM, et al. Providing medical care to methadone clinic patients: referral vs. on-site care. Am J Public Health 1994 Feb;84(2):207-10.
23. Friedmann PD, D'Aunno TA, Jin L, et al. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res 2000 Jun;35(2):443-65.
24. Samet JH, Saitz R, Larson MJ. A case for enhanced linkage of substance abusers to primary medical care. Subst Abus 1996 Sept;17(4):181-99.
25. Friedmann PD, Alexander JA, Jin L, et al. On-site primary care and mental health services in outpatient drug abuse treatment units. J Behav Health Serv Res 1999 Feb;26(1):80-94.
26. D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. J Health Soc Behav 1999 Jun;40(2):175-92.
27. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services. Arch Intern Med 2001 Jan 8;161(1):85-91.
28. D'Aunno TA. Linking substance abuse treatment and primary health care. In: Egertson JA, Fox DM, Leshner AI, eds. Treating drug abusers effectively. Malden, MA: Blackwell, 1997.
29. McLellan AT, Grissom GR, Zanis D, et al. Problem-service "matching" in addiction treatment: a prospective study in 4 programs. Arch Gen Psychiatry 1997 Aug;54(8):730-5.
30. Friedmann PD, Alexander JA, D'Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. J Subst Abuse Treat 1999 Jan;16(1):71-80.
31. Grella CE, Etheridge RM, Joshi V, et al. Delivery of HIV risk-reduction services in drug treatment programs. J Subst Abuse Treat 2000 Oct;19(3):229-37.
32. Price RH. What we know and what we actually do: best practices and their prevalence in substance abuse treatment. In: Egertson JA, Fox DM, Leshner AI, eds. Treating drug abusers effectively. Malden, MA: Blackwell Publishers, 1997.